Policy & Medicine - Legal, Regulatory, and Compliance Issues

Just days before the planned consummation date, the United States Department of Justice sued to intervene in UnitedHealth Group’s…

More than 6 million people in the U.S. are estimated to be living with Alzheimer’s disease (AD), and that number is expected to…

At the recent Healthcare Information and Management Systems Society (HIMSS) 2022 conference in Orlando, Florida, 4Medica CEO Gregg…

In late January 2022, the United States Food and Drug Administration (FDA) issued three guidances (two final and one revised…

Duke-Margolis Center for Public Policy and the Food and Drug Administration (FDA) are hosting a virtual workshop on April 4th and…

The Food and Drug Administration’s Office of Prescription Drug Promotion (OPDP) issued a total of six letters in 2021. Four were…

Robert Califf was narrowly approved in the U.S. Senate and will return to the FDA as its next commissioner. With this in mind, we…

NASH (non-alcoholic steatohepatitis) is a liver disorder characterized by accumulation of fat in the liver and liver scarring. It…

In mid-February 2022, Michigan Governor Gretchen Whitmer signed several pharmacy benefit manager (PBM) reforms into law, including…

On Monday, February 14, 2022, Texas Attorney General Ken Paxton announced a $225 million settlement with Teva Pharmaceutical…